IP Verse

Adaptimmune patent opposition analysis

Get complete Patent Opposition Report for Adaptimmune

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Latest oppositions filed by Adaptimmune

Explore patent oppositions filed by Adaptimmune against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3236985Novel Peptides And Combination Of Peptides For Use In Immunotherapy Against Hepatocellular Carcinoma (Hcc) And Other CancersIMMATICS BIOTECHNOLOGIESJun 25, 2020

Latest patents of Adaptimmune opposed by its competitors

Explore Adaptimmune's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3373013Jul 19, 2023Method For Predicting The Off-Target Biding Of A Peptide Which Binds To A Target Peptide Presented By A Major Histocompatibility Complex3
EP3440104Jun 14, 2023T Cell Receptors1
EP3060668Oct 19, 2022Vectors For Transgene Expression1
EP3116901Jun 12, 2019Tcr Libraries1
EP2936158Feb 13, 2019Method For Predicting The Off-Target Biding Of A Peptide Which Binds To A Target Peptide Presented By A Major Histocompatibility Complex3

Top competitors of Adaptimmune